TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2026

Neoadjuvant docetaxel, oxaliplatin, and S-1 therapy for patients with large type 3 or type 4 gastric cancer: final outcomes of a multicenter, phase II study (OGSG 1902).

Shunji Endo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.